Moteur de recherche d’entreprises européennes
Financement de l’UE (6 162 183 €) : De nouvelles solutions de surveillance à distance non invasive pour assurer la santé des mères et des bébés avant et après la naissance Hor01/01/2023 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
De nouvelles solutions de surveillance à distance non invasive pour assurer la santé des mères et des bébés avant et après la naissance
There is increasing focus on the well being of mothers and babies, both before and after delivery and early detection of pathologies to prevent mother and perinatal morbidity and mortality. The overall well being of mothers also has longer term impact: women who remain healthy during pregnancy and after birth are more likely to stay healthy later in life and have better birth outcomes, also influencing the infancy, childhood and adulthood of their children. NewLife project will develop new remote non-invasive monitoring solutions for ensuring the health of mothers and babies before and after birth. The target is to develop emerging non-invasive methods for gathering vital data and analysing it with advanced AI/ML methods, to be able to secure life in its most vulnerable phase. For clinical acceptance, the developed solutions need to be well integrated to the clinical workflows, with proper data integration, security, safety, and medical qualification. The technologies and solutions developed are demonstrated in five use cases for both hospitals and personalized monitoring in home environments: 1) Pregnancy & parent companion, 2) Smart garment for monitoring of pregnancies & complications, 3) Fetal monitoring patch for high-risk pregnancies, 4) Newborn monitoring with smart clothes, and 5) Newborn monitoring -well being in bed. With the developed solutions, NewLife project will contribute to the disruption of the health care models: by focusing on preventive actions rather than treating diseases, and moving healthcare from hospitals to home.
| AMS International AG | ? |
| AMS Sensors Germany GmbH | 283 784 € |
| Beneli AB | 56 100 € |
| Boston Scientific Ltd. | 62 125 € |
| Club Diabetes B.V. | 0,00 € |
| Cuviva AB | 477 600 € |
| Fraunhofer Gesellschaft ZUR Forderung DER Angewandten Forschung e. V. | 629 555 € |
| Fujitsu Finland Oy | 339 500 € |
| HealthTalk B.V. | 0,00 € |
| Kipuwex AB | 0,00 € |
| Kipuwex Oy | 220 500 € |
| Medrecord B.V. | 294 750 € |
| Nederlandse Organisatie Voor Toegepast Natuurwetenschappelijk Onderzoek TNO | 384 464 € |
| Nirx Medizintechnik GmbH | 361 125 € |
| Noldus Information Technology B.V. | 186 563 € |
| Philips Electronics Nederland B.V. | 681 727 € |
| Philips Medizin Systeme Boblingen GmbH | 214 000 € |
| Rise Research Institutes OF Sweden AB | 263 038 € |
| Sencure B.V. | 241 151 € |
| Technische Universiteit Eindhoven | 439 538 € |
| Teiimo GmbH | 375 863 € |
| Turun Yliopisto | 498 851 € |
| University College Cork - National University of Ireland, Cork | 151 949 € |
https://cordis.europa.eu/project/id/101095792
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : ams International AG, Jona, Suisse.
